CBX6 and CA9 as predictive indicators and therapeutic targets in GBM
{{output}}
Glioblastoma (GBM) is an aggressive primary brain tumor that, partly due to its hypoxic tumor microenvironment (TME), is extremely difficult to treat. In our study, RNA sequencing and quantitative reverse-transcription PCR (qRT-PCR) analysis identified differe... ...
